NSTL国家科技图书文献中心

1. Neurophysiological markers in myelodysplastic syndromes: Insights into peripheral neuropathy NSTL国家科技图书文献中心

Moehn, Nora - 《British Journal of Haematology》 - 2025,206(3) - 1014～1015 - 共2页

摘要： myelodysplastic syndromes (MDS), underscoring the necessity for | with myelodysplastic* syndromes. Br J Haematol 2024* | In their paper, Papantoniou et al. present | relevant findings on the prevalence and characteristics | of peripheral neuropathy in patients with

关键词： myelodysplastic syndromes | neurophysiological markers | peripheral neuropathy

2. GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromes/neoplasms NSTL国家科技图书文献中心

Li, Fuhui | Zhang, Yudi ... - 《Pathology Research and Practice》 - 2025,269 - Article 155930～Article 155930 - 共7页

摘要： expression and dysmegakaryopoiesis in myelodysplastic | syndromes/neoplasm (MDS). We assessed GATA1 expression | GATA1 is one of critical transcription factors | for megakaryopoiesis and platelet production. Our | study aimed to explore the correlations between GATA1

关键词： Myelodysplastic syndromes/neoplasms | GATA1 expression level | Dysmegakaryopoiesis | Abnormal karyotypes | TP53 mutation

3. Clinical and neurophysiological aspects of peripheral neuropathy in patients with myelodysplastic syndromes NSTL国家科技图书文献中心

Papantoniou, Michail | Stergiou, Ioanna ... - 《British Journal of Haematology》 - 2025,206(3) - 864～867 - 共4页 - 被引量：1

摘要：Myelodysplastic syndromes (MDS) are a | heterogeneous group of clonal disorders, manifesting multiple | clinical autoimmune inflammatory phenomena, including | rarely peripheral neuropathy. Twenty-four patients | diagnosed with MDS and 29 healthy subjects were enrolled

关键词： large fibre | myelodysplastic syndromes | peripheral neuropathy | small fibre

4. Real-world impact of luspatercept on red blood cell transfusions among patients with myelodysplastic syndromes: A United States healthcare claims database study NSTL国家科技图书文献中心

Andritsos, Leslie A. | Mcbride, Ali ... - 《Leukemia Research》 - 2025,148 - 107624～107624 - 共9页

摘要：Myelodysplastic syndromes (MDS) are associated | with anemia and the need for blood transfusions. In | clinical trials, luspatercept reduced transfusion | dependency among patients with lower-risk MDS. This United | States (US) study describes real-world clinical

关键词： Lower-risk myelodysplastic syndromes | Red blood cell transfusions | Transfusion dependence | Real-world clinical outcomes

5. Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology NSTL国家科技图书文献中心

Della Porta, Matteo ... | Bewersdorf, Jan Phil...... - 《Histopathology》 - 2025,86(1) - 158～170 - 共13页

摘要：Myelodysplastic syndromes/neoplasms (MDS) and | acute myeloid leukaemia (AML) are neoplastic | haematopoietic cell proliferations that are diagnosed and | classified based on a combination of morphological | , clinical and genetic features. Specifically, the

关键词： acute myeloid leukaemia | classification | cytogenetics | genetics | myelodysplastic syndrome | next-generation sequencing | next‐generation sequencing

6. Place of hematopoietic stem cell transplantation for very high risk acute myeloblastic leukemia and myelodysplastic syndromes (SFGM-TC) NSTL国家科技图书文献中心

Mediavilla, Clemence | D'Aveni, Maud ... - 《Bulletin du Cancer》 - 2025,112(1 Suppl.) - S54～S67 - 共14页

摘要： for acute myeloid leukemia (AML) and myelodysplastic | syndromes (MDS). However, these transplants are | Allogeneic hematopoietic stem cell | transplantation (alloHSCT) is a potentially curative treatment | complicated by a high rate of relapse in very high

关键词： Very high-risk acute | myeloid leukemia | Very high-risk | myelodysplastic syndrome

7. Identification of new candidate drugs in myelodysplastic syndromes with splicing factor mutations by transcriptional profiling and connectivity map analysis NSTL国家科技图书文献中心

Sun, Tianyu | Singh, Shalini ... - 《British Journal of Haematology》 - 2025,206(4) - 1086～1091 - 共6页

摘要： repurposing to myelodysplastic* syndromes (MDS). Connectivity* | We sought to identify new candidate drugs for | map analysis was performed on gene expression | signatures generated from bone marrow CD34+ cells of | splicing factor mutant MDS patients. Celastrol and

关键词： connectivity map | drug repurposing | MDS | splicing factor mutations

8. Preventing relapse of acute leukemias and myelodysplastic syndromes in post-allograft transplantation: Prophylactic and preemptive strategies (SFGM-TC) NSTL国家科技图书文献中心

Coiteux, Valerie | Abellan, Isabelle ... - 《Bulletin du Cancer》 - 2025,112(1 Suppl.) - S111～S124 - 共14页

摘要：Disease relapse remains the fi rst cause of | mortality of hematological malignancies after allogeneic | hematopoietic stem cell transplantation (allo-HCT) for acute | myeloid and lymphoid leukemia (AML and ALL) and for | myelodysplasticsyndroms (MDS). More and more patients are eligible for

关键词： Acute myeloid leukemia | Myelodysplasia | Relapse | Prevention | Allo-HCT

9. Improvement in quality of life in MDS patients who become transfusion independent after treatment NSTL国家科技图书文献中心

Wan, Bo A. | Alibhai, Shabbir M. ...... - 《Leukemia and lymphoma》 - 2025,66(1/2) - 279～288 - 共10页

摘要：Myelodysplastic syndromes (MDSs) treatment | focuses on improving quality of life (QOL), affected by | anemia and transfusion dependence (TD). Using the MDS | -CAN registry, we studied how changes in transfusion | status - TD to transfusion independence (TI) (group A

关键词： Myelodysplastic syndromes | quality of life | transfusion status | hypomethylating agent

10. Characteristics and clinical outcomes of patients with myeloid malignancies and cohesin mutations NSTL国家科技图书文献中心

Maria R Khouri | Bofei Wang ... - 《Cancer.》 - 2025,131(8) - e35846～e35846 - 共10页

摘要：) and myelodysplastic* syndromes (MDS) is controversial* | Background: The prognostic impact of cohesin | mutations in patients with acute myeloid leukemia (AML | . Methods: In patients with AML and MDS who underwent next | -generation sequencing at the authors' center during 2017

摘要： myelodysplastic syndromes (MDS), underscoring the necessity for | with myelodysplastic* syndromes. Br J Haematol 2024* | In their paper, Papantoniou et al. present | relevant findings on the prevalence and characteristics | of peripheral neuropathy in patients with

关键词： myelodysplastic syndromes | neurophysiological markers | peripheral neuropathy

摘要： expression and dysmegakaryopoiesis in myelodysplastic | syndromes/neoplasm (MDS). We assessed GATA1 expression | GATA1 is one of critical transcription factors | for megakaryopoiesis and platelet production. Our | study aimed to explore the correlations between GATA1

关键词： Myelodysplastic syndromes/neoplasms | GATA1 expression level | Dysmegakaryopoiesis | Abnormal karyotypes | TP53 mutation

摘要：Myelodysplastic syndromes (MDS) are a | heterogeneous group of clonal disorders, manifesting multiple | clinical autoimmune inflammatory phenomena, including | rarely peripheral neuropathy. Twenty-four patients | diagnosed with MDS and 29 healthy subjects were enrolled

关键词： large fibre | myelodysplastic syndromes | peripheral neuropathy | small fibre

摘要：Myelodysplastic syndromes (MDS) are associated | with anemia and the need for blood transfusions. In | clinical trials, luspatercept reduced transfusion | dependency among patients with lower-risk MDS. This United | States (US) study describes real-world clinical

关键词： Lower-risk myelodysplastic syndromes | Red blood cell transfusions | Transfusion dependence | Real-world clinical outcomes

摘要：Myelodysplastic syndromes/neoplasms (MDS) and | acute myeloid leukaemia (AML) are neoplastic | haematopoietic cell proliferations that are diagnosed and | classified based on a combination of morphological | , clinical and genetic features. Specifically, the

关键词： acute myeloid leukaemia | classification | cytogenetics | genetics | myelodysplastic syndrome | next-generation sequencing | next‐generation sequencing

摘要： for acute myeloid leukemia (AML) and myelodysplastic | syndromes (MDS). However, these transplants are | Allogeneic hematopoietic stem cell | transplantation (alloHSCT) is a potentially curative treatment | complicated by a high rate of relapse in very high

关键词： Very high-risk acute | myeloid leukemia | Very high-risk | myelodysplastic syndrome

摘要： repurposing to myelodysplastic* syndromes (MDS). Connectivity* | We sought to identify new candidate drugs for | map analysis was performed on gene expression | signatures generated from bone marrow CD34+ cells of | splicing factor mutant MDS patients. Celastrol and

关键词： connectivity map | drug repurposing | MDS | splicing factor mutations

关键词： Acute myeloid leukemia | Myelodysplasia | Relapse | Prevention | Allo-HCT

摘要：Myelodysplastic syndromes (MDSs) treatment | focuses on improving quality of life (QOL), affected by | anemia and transfusion dependence (TD). Using the MDS | -CAN registry, we studied how changes in transfusion | status - TD to transfusion independence (TI) (group A

关键词： Myelodysplastic syndromes | quality of life | transfusion status | hypomethylating agent

摘要：) and myelodysplastic* syndromes (MDS) is controversial* | Background: The prognostic impact of cohesin | mutations in patients with acute myeloid leukemia (AML | . Methods: In patients with AML and MDS who underwent next | -generation sequencing at the authors' center during 2017

关键词： STAG2; acute myeloid leukemia; cohesin; myelodysplastic syndromes

4008-161-200 800-990-8900

国家科技图书文献中心

摘要： myelodysplastic syndromes (MDS), underscoring the necessity for | with myelodysplastic syndromes. Br J Haematol 2024 | In their paper, Papantoniou et al. present | relevant findings on the prevalence and characteristics | of peripheral neuropathy in patients with

关键词： myelodysplastic syndromes | neurophysiological markers | peripheral neuropathy

摘要： expression and dysmegakaryopoiesis in myelodysplastic | syndromes/neoplasm (MDS). We assessed GATA1 expression | GATA1 is one of critical transcription factors | for megakaryopoiesis and platelet production. Our | study aimed to explore the correlations between GATA1

关键词： Myelodysplastic syndromes/neoplasms | GATA1 expression level | Dysmegakaryopoiesis | Abnormal karyotypes | TP53 mutation

摘要：Myelodysplastic syndromes (MDS) are a | heterogeneous group of clonal disorders, manifesting multiple | clinical autoimmune inflammatory phenomena, including | rarely peripheral neuropathy. Twenty-four patients | diagnosed with MDS and 29 healthy subjects were enrolled

关键词： large fibre | myelodysplastic syndromes | peripheral neuropathy | small fibre

摘要：Myelodysplastic syndromes (MDS) are associated | with anemia and the need for blood transfusions. In | clinical trials, luspatercept reduced transfusion | dependency among patients with lower-risk MDS. This United | States (US) study describes real-world clinical

关键词： Lower-risk myelodysplastic syndromes | Red blood cell transfusions | Transfusion dependence | Real-world clinical outcomes

摘要：Myelodysplastic syndromes/neoplasms (MDS) and | acute myeloid leukaemia (AML) are neoplastic | haematopoietic cell proliferations that are diagnosed and | classified based on a combination of morphological | , clinical and genetic features. Specifically, the

关键词： acute myeloid leukaemia | classification | cytogenetics | genetics | myelodysplastic syndrome | next-generation sequencing | next‐generation sequencing

摘要： for acute myeloid leukemia (AML) and myelodysplastic | syndromes (MDS). However, these transplants are | Allogeneic hematopoietic stem cell | transplantation (alloHSCT) is a potentially curative treatment | complicated by a high rate of relapse in very high

关键词： Very high-risk acute | myeloid leukemia | Very high-risk | myelodysplastic syndrome

摘要： repurposing to myelodysplastic syndromes (MDS). Connectivity | We sought to identify new candidate drugs for | map analysis was performed on gene expression | signatures generated from bone marrow CD34+ cells of | splicing factor mutant MDS patients. Celastrol and

关键词： connectivity map | drug repurposing | MDS | splicing factor mutations

关键词： Acute myeloid leukemia | Myelodysplasia | Relapse | Prevention | Allo-HCT

摘要：Myelodysplastic syndromes (MDSs) treatment | focuses on improving quality of life (QOL), affected by | anemia and transfusion dependence (TD). Using the MDS | -CAN registry, we studied how changes in transfusion | status - TD to transfusion independence (TI) (group A

关键词： Myelodysplastic syndromes | quality of life | transfusion status | hypomethylating agent

摘要：) and myelodysplastic syndromes (MDS) is controversial | Background: The prognostic impact of cohesin | mutations in patients with acute myeloid leukemia (AML | . Methods: In patients with AML and MDS who underwent next | -generation sequencing at the authors' center during 2017

关键词： STAG2; acute myeloid leukemia; cohesin; myelodysplastic syndromes

4008-161-200 800-990-8900

国家科技图书文献中心

摘要： myelodysplastic syndromes (MDS), underscoring the necessity for | with myelodysplastic* syndromes. Br J Haematol 2024* | In their paper, Papantoniou et al. present | relevant findings on the prevalence and characteristics | of peripheral neuropathy in patients with

摘要： repurposing to myelodysplastic* syndromes (MDS). Connectivity* | We sought to identify new candidate drugs for | map analysis was performed on gene expression | signatures generated from bone marrow CD34+ cells of | splicing factor mutant MDS patients. Celastrol and

摘要：) and myelodysplastic* syndromes (MDS) is controversial* | Background: The prognostic impact of cohesin | mutations in patients with acute myeloid leukemia (AML | . Methods: In patients with AML and MDS who underwent next | -generation sequencing at the authors' center during 2017